Related Experiment Video
Updated: Aug 15, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Prognostic factors in renal carcinoma
1Department of Medicine, The University of Chicago Hospitals, IL, USA.
Identifying prognostic factors in renal carcinoma (RC) is crucial for tailoring treatments. Key predictors of patient outcome include cancer stage, grade, and performance status (PS), guiding therapy for this challenging malignancy.
Area of Science:
- Oncology
- Urology
Background:
- Renal carcinoma (RC) is a malignancy with poor response to therapies.
- Identifying prognostic factors is essential for optimizing patient treatment strategies.
Purpose of the Study:
- To review prognostic factors influencing overall survival in renal carcinoma patients.
- To explore tumor-, patient-, and treatment-related characteristics impacting patient outcomes.
Main Methods:
- Literature review of studies on prognostic factors in renal carcinoma.
- Analysis of established predictors such as stage, grade, and performance status (PS).
- Exploration of emerging techniques including proliferation markers and cytogenetics.
Main Results:
- Cancer stage, lymph node involvement, venous invasion, and tumor grade are primary outcome predictors.
- Patient performance status (PS) correlates with tumor aggressiveness and treatment tolerance.
- Tumor metastasis characteristics and treatment modalities define patient subgroups with varying survival.
Conclusions:
- Prognostic factor identification enables personalized therapy for renal carcinoma.
- Established factors like stage and grade remain critical for predicting patient survival.
- Further research into novel markers and treatment strategies is ongoing to improve outcomes.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024